The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in the brain which is preventing blood flow), with the RapidPulseTM Aspiration System. Participation in the trial is for 90 days.
The goal of this clinical trials is to demonstrate the safety and effectiveness for the RapidPulseTM Aspiration System in patients experiencing acute ischemic stroke within 8 hours of symptom onset or last seen normal. Subjects will undergo mechanical thrombectomy (a procedure to remove a clot in the brain which is preventing blood flow), with the RapidPulseTM Aspiration System. Participation in the trial is for 90 days.
The Pivotal Study of RapidPulseTM Aspiration System
-
Providence Saint John's Medical Foundation, Torrance, California, United States, 90503
Yale University, New Haven, Connecticut, United States, 06519
Baptist Health Research Institute, Jacksonville, Florida, United States, 32207
University of South Florida, Tampa, Florida, United States, 33620
Emory University at Grady, Atlanta, Georgia, United States, 30303
Rush University Medical Center, Chicago, Illinois, United States, 60612
Advocate Aurora Research Institute, Park Ridge, Illinois, United States, 60068
Indiana University Health, Indianapolis, Indiana, United States, 46202
State University of Iowa, Iowa City, Iowa, United States, 52242
Washington University, Saint Louis, Missouri, United States, 63110
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to 80 Years
ALL
No
RapidPulse, Inc,
Raul G Nogueira, MD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh Medical Center Stroke Institute
Marc Ribó, MD, PRINCIPAL_INVESTIGATOR, Hospital Universitari Vall d' Hebron
2026-12